Honasa Consumer Q2 results: revenue up 36% to Rs 731 crore, EBITDA nearly doubles to Rs 93 crore
Honasa Consumer Q2 results: revenue rose about 36% to Rs 731 crore and EBITDA nearly doubled to Rs 93 crore, the company said.
Honasa Consumer Q2 results for the quarter ended 30 September 2026 show consolidated profit after tax (PAT) of Rs 73.2 crore, up 87% from Rs 39.2 crore a year earlier. Revenue from operations rose 35.9% to Rs 731 crore, which the Mamaearth parent called its highest growth since listing, in filings made on 6 November 2026.
Honasa Consumer Q2 results: key numbers (consolidated)
| Measure (Rs crore) | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 731.2 | 538.1 | +35.9% |
| Total income | 752.9 | 558.2 | +34.9% |
| Profit before tax | 100.8 | 52.7 | +91% |
| Profit after tax | 73.2 | 39.2 | +87% |
| EBITDA (company figure) | 93 | - | nearly doubled |
The company’s press release says EBITDA, a measure of operating profit, “nearly doubled” to Rs 93 crore; it does not give the year-ago figure.
Why Honasa’s profit rose
Its focus categories, which now make up the bulk of sales, grew faster than 40%, helped by general trade, modern trade and e-commerce. Mamaearth grew in the high teens, The Derma Co. grew profitably, and younger brands grew over 45%. General trade reach expanded to about 3.2 lakh outlets.
Expenses grew more slowly than sales: total expenses were Rs 652 crore against Rs 505 crore, up about 29%, so profit grew faster than revenue.
Quarter-on-quarter and one-time items
Compared with the June 2026 quarter, revenue was about 3% lower (Rs 756 crore) and PAT was about 19% lower (Rs 90.4 crore). The September quarter had no exceptional items in the consolidated statement.
What to watch next
Management said it wants to give each brand more independence as it builds a “House of Brands”. In our view, whether growth holds above 30% and whether profit margins keep widening are the points to watch. See our results news.
This article is a summary for information only and is not investment advice. Figures are as reported by the sources above; please verify with the original filing or report before making any decision.
More Results News
See all →- Coromandel International Q2 results: profit falls 33% on fertiliser margin pressure
- Gland Pharma Q2 results: consolidated profit rises 58% and revenue 23% on US and CDMO growth
- Chambal Fertilisers declares Rs 5 interim dividend; Q2 standalone profit up 6% to Rs 635 crore
- Balkrishna Industries Q2 results: profit up 10% on 46% higher revenue; Rs 4 dividend record date 11 November
- Bosch Q2 results: consolidated profit rises 19% to Rs 840 crore; board approves 1:5 split and 3:1 bonus